Kaur Kirandeep, Aeron Shelly, Bruhaspathy Miriyala, Shetty Shankar J, Gupta Suman, Hegde Laxminarayan H, Silamkoti Arun D V, Mehta Anita, Chugh Anita, Gupta Jang B, Sarma P K S, Kumar Naresh
Ranbaxy Research Laboratories, New Drug Discovery Research, Department of Medicinal Chemistry, Gurgaon 122 001, Haryana, India.
Bioorg Med Chem Lett. 2005 Apr 15;15(8):2093-6. doi: 10.1016/j.bmcl.2005.02.036.
Novel derivatives of Tolterodine (1) and Oxybutynin (2) have been designed using conformationally restricted azabicyclics as replacement for open-chain amines. The synthesis and structure-activity relationships are presented.
已设计出用构象受限的氮杂双环化合物替代开链胺的托特罗定(1)和奥昔布宁(2)的新型衍生物。本文介绍了其合成方法及构效关系。